- Home
- NBY vs SNEX Comparison
NBY vs SNEX Comparison
Compare NBY & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- SNEX
- Stock Information
- Founded
- NBY 2000
- SNEX 1924
- Country
- NBY United States
- SNEX United States
- Employees
- NBY N/A
- SNEX N/A
- Industry
- NBY
- SNEX Investment Bankers/Brokers/Service
- Sector
- NBY
- SNEX Finance
- Exchange
- NBY Nasdaq
- SNEX Nasdaq
- Market Cap
- NBY 3.4M
- SNEX 4.1B
- IPO Year
- NBY 2007
- SNEX 1994
- Fundamental
- Price
- NBY $0.69
- SNEX $93.84
- Analyst Decision
- NBY Strong Buy
- SNEX Buy
- Analyst Count
- NBY 1
- SNEX 1
- Target Price
- NBY $0.85
- SNEX N/A
- AVG Volume (30 Days)
- NBY 29.9K
- SNEX 416.2K
- Earning Date
- NBY 08-12-2025
- SNEX 08-05-2025
- Dividend Yield
- NBY N/A
- SNEX N/A
- EPS Growth
- NBY N/A
- SNEX 17.88
- EPS
- NBY 0.57
- SNEX 5.90
- Revenue
- NBY $9,781,000.00
- SNEX $121,723,000,000.00
- Revenue This Year
- NBY $23.91
- SNEX N/A
- Revenue Next Year
- NBY $32.05
- SNEX $0.21
- P/E Ratio
- NBY $1.52
- SNEX $15.50
- Revenue Growth
- NBY 20.52
- SNEX 68.26
- 52 Week Low
- NBY $0.36
- SNEX $47.69
- 52 Week High
- NBY $2.33
- SNEX $99.08
- Technical
- Relative Strength Index (RSI)
- NBY 67.97
- SNEX 59.48
- Support Level
- NBY $0.60
- SNEX $90.87
- Resistance Level
- NBY $0.70
- SNEX $99.08
- Average True Range (ATR)
- NBY 0.05
- SNEX 2.54
- MACD
- NBY 0.01
- SNEX 0.27
- Stochastic Oscillator
- NBY 66.67
- SNEX 56.39
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.